1. ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice
   Lakshini Weerasekera et al, 2017, Mediators of Inflammation CrossRef
2. The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
   Sophia Harlid et al, 2017, Mediators of Inflammation CrossRef
3. Identification of three genetic variants as novel susceptibility loci for body mass index in a Japanese population
   Yoshiki Yasukochi et al, 2018, Physiological Genomics CrossRef
4. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality.
   C Fernandez et al, 2018, J Intern Med CrossRef
5. A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes
   Chiara Zusi et al, 2018, Diabetes Research and Clinical Practice CrossRef
6. The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9
   Nabil G. Seidah et al, 2017, Pharmacol Rev CrossRef
7. The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia
   Martine Paquette et al, 2020, Journal of Clinical Lipidology CrossRef
8. Impact of Diabetes in Patients Diagnosed With COVID-19
   Mohamed Abu-Farha et al, 2020, Front. Immunol. CrossRef
9. Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9
   Carlota Oleaga et al, 2021, Journal of Lipid Research CrossRef
10. Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell Dysfunction
    Bas Brouwers et al, 2021, Diabetes CrossRef
11. Mouse Models of Human Proprotein Convertase Insufficiency
    Manita Shakya et al, 2020 CrossRef
12. Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population
    Robert W. Read et al, 2021, Front. Genet. CrossRef
13. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification
    Vince Kornél Grolmusz et al, 2021, Front. Immunol. CrossRef
14. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry
    Georgia Ragia et al, 2020, Pharmacogenomics CrossRef
15. Effect of FURIN SNP rs17514846 on coronary atherosclerosis in human cardiac specimens: an autopsy study of 106 cases
    Gentaro Yamasaki et al, 2021, Legal Medicine CrossRef
16. Association Between Serum Furin and Fasting Glucose: A Cross-Sectional Study in Chinese Adults
    Yan He et al, 2022, Front. Endocrinol. CrossRef
17. FURIN Promoter Methylation Predicts the Risk of Incident Diabetes: A Prospective Analysis in the Gusu Cohort
    Yan He et al, 2022, Front. Endocrinol. CrossRef
18. Deficient serum furin predicts risk of abdominal obesity: findings from a prospective cohort of Chinese adults.
    Yan He et al, 2021, Postgrad Med J CrossRef
19. Association between Genetic Variants of CELSR2-PSRC1-SORT1 and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
    Rosa Giannina Castillo-Avila et al, 2023, JCDD CrossRef
20. Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar
    Dalal Al‐Sharshani et al, 2023, Molec Gen & Gen Med CrossRef
21. Pediatric Non-Alcoholic Fatty Liver Disease is Affected by Genetic Variants Involved in Lifespan/Healthspan.
    Annalisa Crudele et al, 2021, J Pediatr Gastroenterol Nutr CrossRef
22. The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk
    Hannah Fry et al, 2024, IJMS CrossRef
23. Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank
    Lars Lind et al, 2024, Nat Cardiovasc Res CrossRef